Federal Register / Vol. 62, No. 230 / Monday, December 1, 1997 / Notices 63551

Dated: November 24, 1997.

John C. Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–31351 Filed 11–28–97; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Epidemiology Program Office, Office of

the Director, Centers for Disease

Control and Prevention (CDC),

Announces the Following Meeting

Name: Guide to Community

Preventive Services (GCPS) Task Force

Meeting.

Times and Dates: 8 a.m.–5:30 p.m.,

December 15, 1997; 8 a.m.–4 p.m.,

December 16, 1997.

Place: Westin Peachtree Plaza, 210

Peachtree Street, Atlanta, Georgia

30326.

Status: Open to the public, limited

only by the space available.

Purpose: The mission of the Task

Force is to develop and publish a Guide

to Community Preventive Services,

based on the best available scientific

evidence and current expertise

regarding essential public health

services and what works in the delivery

of those services.

Matters To Be Considered: Agenda

items include (1) presentations and

review of evidence tables and draft

recommendations of interventions for

the Vaccine Preventable Diseases and

Motor Vehicle Occupant Injuries

Chapters; (2) a discussion on the

development of an explicit process to

incorporate cost effectiveness into the

development of the Guide; (3) a

discussion on the role of the expert

opinion in the development of the

Guide; (4) organization of draft standalone topics and/or chapters; (5) a

review of the plans to field test, and

‘‘roll out’’ sections of the Guide; and (6)

a report from the Table of Contents

Work Group regarding proposed

introductory material ‘‘Front Matter’’ in

the Guide.

Agenda items are subject to change as

priorities dictate.

Contact Person for Additional

Information: Marguerite Pappaioanou,

Chief, Community Preventive Service

Guide Development Activity, Division

of Prevention Research and Analytic

Methods, Epidemiology Program Office,

CDC, 1600 Clifton Road, NE, M/S D–01,

Atlanta, Georgia 30333, telephone 404/

639–4301. Persons wishing to reserve a

space for this meeting should call 404/

639–4301 by close of business on

December 10, 1997.

Dated: November 24, 1997.

John C. Burckhardt,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–31350 Filed 11–28–97; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0353]

Agency Information Collection

Activities; Announcement of OMB

Approval

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Food Additives and Food Additive

Petitions’’ has been approved by the

Office of Management and Budget

(OMB) under the Paperwork Reduction

Act of 1995 (the PRA).

FOR FURTHER INFORMATION CONTACT:

Margaret R. Schlosburg, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In the

Federal Register of September 3, 1997

(62 FR 46500), the agency announced

that the proposed information collection

had been submitted to OMB for review

and clearance under section 3507 of the

PRA (44 U.S.C. 3507). An agency may

not conduct or sponsor, and a person is

not required to respond to, a collection

of information unless it displays a

currently valid OMB control number.

OMB has now approved the information

collection and has assigned OMB

control number 0910–0016. The

approval expires on November 30, 2000.

Dated: November 20, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–31365 Filed 11-28-97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–R–52]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Revision of a currently

approved collection; Title of

Information Collection: Conditions for

Coverage of Suppliers of End Stage

Renal Disease (ESRD) Services and

Supporting Regulations Contained in 42

CFR 405.2100–.2171; Document No.:

HCFA–R–52 (OMB#0938–0386); Use:

These conditions of coverage are needed

to ensure proper distribution and

effective utilization of ESRD treatment

sources. In addition, the conditions

maintain and improve the efficient

delivery of care by physicians and

dialysis facilities.; Frequency: Annually;

Affected Public: Business or other forprofit, and Federal Government;

Number of Respondents: 2,976; Total

Annual Responses: 2,976; Total Annual

Hours: 100,937.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address, phone number,

OMB number, and HCFA document

identifier to Paperwork@hcfa.gov, or

call the Reports Clearance Office on

(410) 786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to
63552 Federal Register / Vol. 62, No. 230 / Monday, December 1, 1997 / Notices

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: Louis

Blank, Room C2–26–17 7500 Security

Boulevard, Baltimore, Maryland 21244–

1850.

Dated: November 19, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards.

[FR Doc. 97–31316 Filed 11–28–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–R–170 and R–108]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

1. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Criteria for

Medicare Coverage of Lung Transplants;

Form No.: HCFA–R–170 (OMB# 0938–

0670); Use: Medicare participating

hospitals must file an application to be

approved for coverage and payment of

lung transplants performed on Medicare

beneficiaries; Frequency: Annually;

Affected Public: Business or other forprofit; Number of Respondents: 16;

Total Annual Responses: 16; Total

Annual Hours: 1,910.

2. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Criteria for

Medicare Coverage of Liver Transplants;

Form No.: HCFA–R–108 (OMB# 0938–

0580); Use: Medicare participating

hospitals must file an application to be

approved for coverage and payment of

liver transplants performed on Medicare

beneficiaries; Frequency: Annually;

Affected Public: Business or other forprofit; Number of Respondents: 12;

Total Annual Responses: 12; Total

Annual Hours: 1,880.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address, phone number,

OMB number, and HCFA document

identifier, to Paperwork@hcfa.gov, or

call the Reports Clearance Office on

(410) 786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: Louis

Blank, Room C2–26–17, 7500 Security

Boulevard, Baltimore, Maryland 21244–

1850.

Dated: November 20, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards.

[FR Doc. 97–31317 Filed 11–28–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date of Meeting: December 5, 1997

(Telephone Conference).

Time: 11:30 a.m. to adjournment.

Place of Meeting: Willco Building, 6000

Executive Boulevard, Suite 409, Rockville

MD 20892–7003.

Contact Person: Elsie Taylor, 6000

Executive Boulevard, Suite 409, Rockville

MD 20892–7003, 301–443–9787.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

proposal and discussions could reveal

confidential trade secrets or commercial

property such as patentable material, and

personal information concerning individuals

associated with the proposal, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

(Catalog of Federal Domestic Assistance,

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

and 93.891, Alcohol Research Center Grants;

National Institutes of Health.)

Dated: November 24, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–31416 Filed 11–28–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Therapeutic Strategies for

Papillomavirus (Telephone Conference Call).

Date: December 17, 1997.

Time: 2:00 p.m. to Adjournment.

Place: Teleconference, 6003 Executive

Blvd., Solar Building, Room 1A1, Bethesda,

MD 20892, (301) 402–0747.

Contact Person: Rosemary McCabe Hamill,

Technical Evaluation Admin., 6003

Executive Boulevard, Solar Bldg., Room

3C03, Bethesda, MD 20892, (301) 496–0384.

Purpose/Agenda: To evaluate contract

proposal.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure